<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cardiovascular</journal-id><journal-title-group><journal-title xml:lang="ru">Кардиоваскулярная терапия и профилактика</journal-title><trans-title-group xml:lang="en"><trans-title>Cardiovascular Therapy and Prevention</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1728-8800</issn><issn pub-type="epub">2619-0125</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15829/1728-8800-2026-4697</article-id><article-id custom-type="edn" pub-id-type="custom">HFVAVY</article-id><article-id custom-type="elpub" pub-id-type="custom">cardiovascular-4697</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>АРТЕРИАЛЬНАЯ ГИПЕРТОНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ARTERIAL HYPERTENSION</subject></subj-group></article-categories><title-group><article-title>Методы определения возраста сосудов у мужчин молодого и среднего возраста с артериальной гипертензией</article-title><trans-title-group xml:lang="en"><trans-title>Methods of vascular age estimation in young and middle-aged men with hypertension</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0068-8071</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Савичева</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Savicheva</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Савичева Алена Алексеевна — аспирант отдела фундаментальных и прикладных аспектов ожирения.</p><p>Петроверигский пер., 10, стр. 3, Москва, 101990</p></bio><bio xml:lang="en"><p>Petroverigsky Lane, 10, bld. 3, Moscow, 101990</p></bio><email xlink:type="simple">alyona.sawi4ewa@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1002-1895</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бернс</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Berns</surname><given-names>S. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бернс Светлана Александровна — д.м.н., руководитель лаборатории патогенетических аспектов коморбидности, профессор кафедры терапии института профессионального образования и аккредитации.</p><p>Петроверигский пер., 10, стр. 3, Москва, 101990</p></bio><bio xml:lang="en"><p>Petroverigsky Lane, 10, bld. 3, Moscow, 101990</p></bio><email xlink:type="simple">svberns@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9332-0622</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Имаева</surname><given-names>А. Э.</given-names></name><name name-style="western" xml:lang="en"><surname>Imaeva</surname><given-names>A. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Имаева Асия Эмверовна — д.м.н., в.н.с. отдела эпидемиологии хронических неинфекционных заболеваний.</p><p>Петроверигский пер., 10, стр. 3, Москва, 101990</p></bio><bio xml:lang="en"><p>Petroverigsky Lane, 10, bld. 3, Moscow, 101990</p></bio><email xlink:type="simple">AImaeva@gnicpm.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8011-2798</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Баланова</surname><given-names>Ю. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Balanova</surname><given-names>Yu. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Баланова Юлия Андреевна — д.м.н., в.н.с. отдела эпидемиологии хронических неинфекционных заболеваний.</p><p>Петроверигский пер., 10, стр. 3, Москва, 101990</p></bio><bio xml:lang="en"><p>Petroverigsky Lane, 10, bld. 3, Moscow, 101990</p></bio><email xlink:type="simple">JBalanova@gnicpm.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8939-0716</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Исайкина</surname><given-names>О. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Isaykina</surname><given-names>O. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Исайкина Олеся Юрьевна — к.м.н., в.н.с. лаборатории применения амбулаторных диагностических методов в профилактике хронических неинфекционных заболеваний.</p><p>Петроверигский пер., 10, стр. 3, Москва, 101990</p></bio><bio xml:lang="en"><p>Petroverigsky Lane, 10, bld. 3, Moscow, 101990</p></bio><email xlink:type="simple">oisaykina@gnicpm.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1423-214X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Горшков</surname><given-names>А. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Gorshkov</surname><given-names>A. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>К.м.н., зам. директора по научной и амбулаторно-поликлинической работе.</p><p>Петроверигский пер., 10, стр. 3, Москва, 101990</p></bio><bio xml:lang="en"><p>Petroverigsky Lane, 10, bld. 3, Moscow, 101990</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4453-8430</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Драпкина</surname><given-names>О. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Drapkina</surname><given-names>O. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Д.м.н., профессор, академик РАН, директор.</p><p>Петроверигский пер., 10, стр. 3, Москва, 101990</p></bio><bio xml:lang="en"><p>Petroverigsky Lane, 10, bld. 3, Moscow, 101990</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ "Национальный медицинский исследовательский центр терапии и профилактической медицины" Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Medical Research Center for Therapy and Preventive Medicine</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>31</day><month>07</month><year>2026</year></pub-date><volume>25</volume><issue>6</issue><fpage>4697</fpage><lpage>4697</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Савичева А.А., Бернс С.А., Имаева А.Э., Баланова Ю.А., Исайкина О.Ю., Горшков А.Ю., Драпкина О.М., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Савичева А.А., Бернс С.А., Имаева А.Э., Баланова Ю.А., Исайкина О.Ю., Горшков А.Ю., Драпкина О.М.</copyright-holder><copyright-holder xml:lang="en">Savicheva A.A., Berns S.A., Imaeva A.E., Balanova Y.A., Isaykina O.Y., Gorshkov A.Y., Drapkina O.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://cardiovascular.elpub.ru/jour/article/view/4697">https://cardiovascular.elpub.ru/jour/article/view/4697</self-uri><abstract><sec><title>Цель</title><p>Цель. Провести анализ применения калькуляторов биологического возраста, отражающих старение сердца и сосудистой стенки, у пациентов молодого и среднего возраста с артериальной гипертензией (АГ).</p></sec><sec><title>Материал и методы</title><p>Материал и методы. Всего обследовано 205 пациентов мужского пола, молодого и среднего возраста (30-55 лет) с офисным систолическим артериальным давлением 140-179 мм рт.ст. и/или диастолическим артериальным давлением 90-109 мм рт.ст. У пациентов оценивали антропометрические, лабораторные и инструментальные показатели. Пациенты были разделены на три группы: 1 группа — индекс массы тела (ИМТ) &lt;25 кг/м2, 2 группа — 25≤ ИМТ &lt;30 кг/м2 и 3 группа — ИМТ ≥30 кг/м2. Биологический возраст оценивали с использованием калькулятора, основанного на Фремингемской шкале риска сердечно-сосудистых заболеваний, и калькулятора QRISK3.</p></sec><sec><title>Результаты</title><p>Результаты. При расчете "сердечно-сосудистого возраста" по калькулятору, основанному на Фремингемской шкале, пациенты с артериальной гипертензией (АГ) были существенно старше по сравнению с лицами с изолированной офисной АГ (ИОАГ) (р&lt;0,001). "Сердечно-сосудистый возраст", рассчитанный при помощи калькулятора QRISK3, у пациентов с АГ был достоверно (р&lt;0,001) выше в сравнении с пациентами с ИОАГ. Пациенты с АГ характеризовались достоверно большей величиной ИМТ (р&lt;0,001), окружности талии (р&lt;0,001) и окружности бедер (р=0,008), толщиной комплекса имнтима-медиа общей сонной артерии (р=0,013), расчетного индекса аугментации в %, корригированного по частоте сердечных сокращений 75 уд./мин (Alp75) (р&lt;0,001), возраста сосудистой системы (VA) (р=0,023), индекса отражения (RI) (р&lt;0,001), уровня холестерина (ХС) (р=0,72), ХС липопротеинов низкой плотности (р=0,56), ХС липопротеинов очень низкой плотности (р&lt;0,001), триглицеридов (р&lt;0,001), С-реактивного белка, определенного высокочувствительным методом (р=0,021), и меньшим значением уровня ХС липопротеинов высокой плотности (р=0,002) по сравнению с лицами с ИОАГ. При проведении сравнительного анализа величины биологического возраста выявлены статистически значимые различия у пациентов с АГ, который был достоверно (р=0,006) выше при наличии ИМТ ≥30 кг/м2 по сравнению с пациентами с ИМТ &lt;25 кг/м2.</p></sec><sec><title>Заключение</title><p>Заключение. Полученные результаты подтверждают вклад АГ и ожирения в преждевременное старение сосудистой стенки и, как следствие, всего организма в целом.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim. To analyze the use of biological age calculators reflecting cardiac and vascular aging in young and middle-aged patients with hypertension (HTN).</p></sec><sec><title>Material and methods</title><p>Material and methods. A total of 205 young and middle-aged male patients (30-55 years) with office systolic blood pressure of 140-179 mm Hg and/or diastolic blood pressure of 90-109 mm Hg were examined. Anthropometric, laboratory, and imaging parameters were assessed. Patients were divided into three groups: Group 1 — body mass index (BMI) &lt;25 kg/m2, Group 2 — 25≤ BMI &lt;30 kg/m2, and Group 3 — BMI ≥30 kg/m2. Biological age was estimated using the Framingham risk score calculator and the QRISK3 calculator.</p></sec><sec><title>Results</title><p>Results. When calculating cardiovascular age using the Framingham risk score calculator, patients with HTN were significantly older compared to those with isolated office hypertension (IOH) (p&lt;0,001). Cardiovascular age calculated using the QRISK3 calculator was significantly (p&lt;0,001) higher in patients with hypertension compared to those with IOH. Patients with HTN were characterized by significantly higher BMI (p&lt;0,001), waist circumference (p&lt;0,001) and hip circumference (p=0,008), common carotid artery intima-media thickness (p=0,013), estimated augmentation index in %, adjusted for heart rate of 75 bpm (Alp75) (p&lt;0,001), vascular age (VA) (p=0,023), reflection index (RI) (p&lt;0,001), cholesterol (p=0,72), low-density lipoprotein (LDL) (p=0,56), very low-density lipoprotein (VLDL) (p&lt;0,001), triglycerides (p&lt;0,001), high-sensitivity C-reactive protein (p=0,021), and a lower high-density lipoprotein (p=0,002) compared to individuals with IOH. A comparative analysis of biological age revealed significant differences in patients with HTN, which was significantly (p=0,006) higher in those with a BMI ≥30 kg/m2 compared to those with a BMI &lt;25 kg/m2.</p></sec><sec><title>Conclusion</title><p>Conclusion. The obtained results confirm the contribution of HTN and obesity to the early vascular aging and, consequently, the entire body.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>артериальная гипертензия</kwd><kwd>жесткость артерий</kwd><kwd>биологический возраст</kwd><kwd>калькулятор</kwd><kwd>старение</kwd><kwd>молодой и средний возраст</kwd><kwd>сердечно-сосудистые заболевания</kwd></kwd-group><kwd-group xml:lang="en"><kwd>hypertension</kwd><kwd>arterial stiffness</kwd><kwd>biological age</kwd><kwd>calculator</kwd><kwd>aging</kwd><kwd>young and middle age</kwd><kwd>cardiovascular disease</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование проводилось в рамках государственного задания "Разработка экспертной системы оценки "успешного старения" населения РФ, с учетом психологического и физического состояния здоровья в качестве инструмента прогнозирования популяционного и индивидуального риска".</funding-statement><funding-statement xml:lang="en">The study was conducted within the state assignment "Development of an expert system for assessing the "successful aging" of the Russian population, taking into account psychological and physical health as a tool for predicting population and individual risk".</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Бойцов С. А., Шальнова С. А., Деев А. Д. Эпидемиологическая ситуация как фактор, определяющий стратегию действий по снижению смертности в Российской Федерации. Терапевтический архив. 2020;92(1):4-9. doi:10.26442/00403660.2020.01.000510.</mixed-citation><mixed-citation xml:lang="en">Boytsov SA, Shalnova SA, Deev AD. The epidemiological situation as a factor determining the strategy for reducing mortality in the Russian Federation. Therapeutic Archive. 2020;92(1):4-9. (In Russ.) doi:10.26442/00403660.2020.01.000510.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Shlyakhto E, Levina A, Dubgorn A, et al. Medical innovation hubs as an organizational and technological form of accelerating healthcare development. Lect Notes Netw Syst. 2022;387:289-97. doi:10.1007/978-3-030-93872-7_24.</mixed-citation><mixed-citation xml:lang="en">Shlyakhto E, Levina A, Dubgorn A, et al. Medical innovation hubs as an organizational and technological form of accelerating healthcare development. Lect Notes Netw Syst. 2022;387:289-97. doi:10.1007/978-3-030-93872-7_24.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018; 39(33):3021-104. doi:10.1093/eurheartj/ehy339.</mixed-citation><mixed-citation xml:lang="en">Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018; 39(33):3021-104. doi:10.1093/eurheartj/ehy339.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Kaess BM, Rong J, Larson MG, et al. Aortic stiffness, blood pressure progression, and incident hypertension. JAMA. 2012; 308(9):875-81. doi:10.1001/2012.jama.10503.</mixed-citation><mixed-citation xml:lang="en">Kaess BM, Rong J, Larson MG, et al. Aortic stiffness, blood pressure progression, and incident hypertension. JAMA. 2012; 308(9):875-81. doi:10.1001/2012.jama.10503.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Laurent S, Boutouyrie P, Cunha PG, et al. Concept of extremes in vascular aging. Hypertension. 2019;74(2):218-28. doi:10.1161/HYPERTENSIONAHA.119.12655.</mixed-citation><mixed-citation xml:lang="en">Laurent S, Boutouyrie P, Cunha PG, et al. Concept of extremes in vascular aging. Hypertension. 2019;74(2):218-28. doi:10.1161/HYPERTENSIONAHA.119.12655.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Nilsson PM. Early Vascular Aging in Hypertension. Front Cardiovasc Med. 2020;7:6. doi:10.3389/fcvm.2020.00006. EDN: DKWAMD.</mixed-citation><mixed-citation xml:lang="en">Nilsson PM. Early Vascular Aging in Hypertension. Front Cardiovasc Med. 2020;7:6. doi:10.3389/fcvm.2020.00006. EDN: DKWAMD.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ben-Shlomo Y, Spears M, Boustred C, et al. Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects. J Am Coll Cardiol. 2014;63(7):636-46. doi:10.1016/j.jacc.2013.09.063.</mixed-citation><mixed-citation xml:lang="en">Ben-Shlomo Y, Spears M, Boustred C, et al. Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects. J Am Coll Cardiol. 2014;63(7):636-46. doi:10.1016/j.jacc.2013.09.063.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Mitchell GF, Hwang SJ, Vasan RS, et al. Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation. 2010;121(4):505-11. doi:10.1161/CIRCULATIONAHA.109.886655.</mixed-citation><mixed-citation xml:lang="en">Mitchell GF, Hwang SJ, Vasan RS, et al. Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation. 2010;121(4):505-11. doi:10.1161/CIRCULATIONAHA.109.886655.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Чазова И. Е., Жернакова Ю. В. Диагностика и лечение артериальной гипертонии. Системные гипертензии. 2019;16(1):6-31. doi:10.26442/2075082X.2019.1.190179.</mixed-citation><mixed-citation xml:lang="en">Chazova IE, Zhernakova Yu V. Diagnosis and treatment of arterial hypertension [Guidelines]. Systemic Hypertension. 2019;16(1):6-31. (In Russ.) doi:10.26442/2075082X.2019.1.190179.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Chen W, Li S, Fernandez C, et al. Temporal Relationship Between Elevated Blood Pressure and Arterial Stiffening Among Middle-Aged Black and White Adults: The Bogalusa Heart Study. Am J Epidemiol. 2016;183(7):599-608. doi:10.1093/aje/kwv274.</mixed-citation><mixed-citation xml:lang="en">Chen W, Li S, Fernandez C, et al. Temporal Relationship Between Elevated Blood Pressure and Arterial Stiffening Among Middle-Aged Black and White Adults: The Bogalusa Heart Study. Am J Epidemiol. 2016;183(7):599-608. doi:10.1093/aje/kwv274.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Арутюнов А. Г., Ноздрин А. В., Шавгулидзе К. Б. и др. Различия паспортного и биологического (фактического) возраста в популяции российских пациентов, страдающих артериальной гипертензией (анализ регистра "ГИПЕРИОН"). Терапевтический архив. 2018;90(4):21-8. EDN: WBXTXN.</mixed-citation><mixed-citation xml:lang="en">Arutyunov AG, Nozdrin AV, Shavgulidze KB, et al. Differences between passport and biological (actual) age in the population of Russian patients suffering from arterial hypertension (analysis of the "Hyperion" register). Therapeutic Archive. 2018;90(4):21-8. (In Russ.) EDN: WBXTXN.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Bleakley C, Hamilton PK, Pumb R, et al. Endothelial Function in Hypertension: Victim or Culprit? J Clin Hypertens (Greenwich). 2015;17(8):651-4. doi:10.1111/jch.12546.</mixed-citation><mixed-citation xml:lang="en">Bleakley C, Hamilton PK, Pumb R, et al. Endothelial Function in Hypertension: Victim or Culprit? J Clin Hypertens (Greenwich). 2015;17(8):651-4. doi:10.1111/jch.12546.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Torimoto K, Okada Y, Tanaka Y. Type 2 Diabetes and Vascular Endothelial Dysfunction. [Article in Japanese]. J UOEH. 2018; 40(1):65-75. doi:10.7888/juoeh.40.65.</mixed-citation><mixed-citation xml:lang="en">Torimoto K, Okada Y, Tanaka Y. Type 2 Diabetes and Vascular Endothelial Dysfunction. [Article in Japanese]. J UOEH. 2018; 40(1):65-75. doi:10.7888/juoeh.40.65.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">AlGhatrif M, Strait JB, Morrell CH, et al. Longitudinal trajectories of arterial stiffness and the role of blood pressure: the Baltimore Longitudinal Study of Aging. Hypertension. 2013;62:934-41. doi:10.1161/HYPERTENSIONAHA.113.01445.</mixed-citation><mixed-citation xml:lang="en">AlGhatrif M, Strait JB, Morrell CH, et al. Longitudinal trajectories of arterial stiffness and the role of blood pressure: the Baltimore Longitudinal Study of Aging. Hypertension. 2013;62:934-41. doi:10.1161/HYPERTENSIONAHA.113.01445.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Jiang L, Zhang J, Monticone RE, et al. Calpain-1 regulation of matrix metalloproteinase 2 activity in vascular smooth muscle cells facilitates age-associated aortic wall calcification and fibrosis. Hypertension. 2012;60:1192-9. doi:10.1161/HYPERTENSIONAHA.112.196840.</mixed-citation><mixed-citation xml:lang="en">Jiang L, Zhang J, Monticone RE, et al. Calpain-1 regulation of matrix metalloproteinase 2 activity in vascular smooth muscle cells facilitates age-associated aortic wall calcification and fibrosis. Hypertension. 2012;60:1192-9. doi:10.1161/HYPERTENSIONAHA.112.196840.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Rosano C, Watson N, Chang Y, et al. Aortic pulse wave velocity predicts focal white matter hyperintensities in a biracial cohort of older adults. Hypertension. 2013;61:160-5. doi:10.1161/HYPERTENSIONAHA.112.198069.</mixed-citation><mixed-citation xml:lang="en">Rosano C, Watson N, Chang Y, et al. Aortic pulse wave velocity predicts focal white matter hyperintensities in a biracial cohort of older adults. Hypertension. 2013;61:160-5. doi:10.1161/HYPERTENSIONAHA.112.198069.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Ong KL, Cheung BM, Man YB, et al. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999–2004. Hypertension. 2007;49:69-75. doi:10.1161/01.HYP.0000252676.46043.18.</mixed-citation><mixed-citation xml:lang="en">Ong KL, Cheung BM, Man YB, et al. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999–2004. Hypertension. 2007;49:69-75. doi:10.1161/01.HYP.0000252676.46043.18.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Gerhard-Herman M, Smoot LB, Wake N, et al. Mechanisms of premature vascular aging in children with hutchinson-gilford progeria syndrome. Hypertension. 2012;59:92-7. doi:10.1161/HYPERTENSIONAHA.111.180919.</mixed-citation><mixed-citation xml:lang="en">Gerhard-Herman M, Smoot LB, Wake N, et al. Mechanisms of premature vascular aging in children with hutchinson-gilford progeria syndrome. Hypertension. 2012;59:92-7. doi:10.1161/HYPERTENSIONAHA.111.180919.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Sun Z. Aging, arterial stiffness, and hypertension. Hypertension. 2015;65:252-6. doi:10.1161/HYPERTENSIONAHA.114.03617.</mixed-citation><mixed-citation xml:lang="en">Sun Z. Aging, arterial stiffness, and hypertension. Hypertension. 2015;65:252-6. doi:10.1161/HYPERTENSIONAHA.114.03617.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Nilsson PM. Early Vascular Ageing — A Concept in Development. Eur Endocrinol. 2015;11(1):26-31. doi:10.17925/EE.2015.11.01.26.</mixed-citation><mixed-citation xml:lang="en">Nilsson PM. Early Vascular Ageing — A Concept in Development. Eur Endocrinol. 2015;11(1):26-31. doi:10.17925/EE.2015.11.01.26.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Fuentes E, Fuentes F, Vilahur G, et al. Mechanisms of chronic state of inflammation as mediators that link obese adipose tissue and metabolic syndrome. Mediators Inflamm. 2013;2013:136584. doi:10.1155/2013/136584.</mixed-citation><mixed-citation xml:lang="en">Fuentes E, Fuentes F, Vilahur G, et al. Mechanisms of chronic state of inflammation as mediators that link obese adipose tissue and metabolic syndrome. Mediators Inflamm. 2013;2013:136584. doi:10.1155/2013/136584.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Gomez-Sanchez M, Gomez-Sanchez L, Patino-Alonso MC, et al. Vascular aging and its relationship with lifestyles and other risk factors in the general Spanish population: Early Vascular Ageing Study. J Hypertens. 2020;38(6):1110-22. doi:10.1097/HJH.0000000000002373.</mixed-citation><mixed-citation xml:lang="en">Gomez-Sanchez M, Gomez-Sanchez L, Patino-Alonso MC, et al. Vascular aging and its relationship with lifestyles and other risk factors in the general Spanish population: Early Vascular Ageing Study. J Hypertens. 2020;38(6):1110-22. doi:10.1097/HJH.0000000000002373.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Cavero-Redondo I, Saz-Lara A, Martínez-García I, et al. Validation of an early vascular aging construct model for comprehensive cardiovascular risk assessment using external risk indicators for improved clinical utility: data from the EVasCu study. Cardiovasc Diabetol. 2024;23(1):33. doi:10.1186/s12933-023-02104-y.</mixed-citation><mixed-citation xml:lang="en">Cavero-Redondo I, Saz-Lara A, Martínez-García I, et al. Validation of an early vascular aging construct model for comprehensive cardiovascular risk assessment using external risk indicators for improved clinical utility: data from the EVasCu study. Cardiovasc Diabetol. 2024;23(1):33. doi:10.1186/s12933-023-02104-y.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Hansen TW, Jeppesen J, Rasmussen S, et al. Relation between insulin and aortic stiffness: a population-based study. J Hum Hyper tens. 2004;18:1-7. doi:10.1038/sj.jhh.1001620.</mixed-citation><mixed-citation xml:lang="en">Hansen TW, Jeppesen J, Rasmussen S, et al. Relation between insulin and aortic stiffness: a population-based study. J Hum Hyper tens. 2004;18:1-7. doi:10.1038/sj.jhh.1001620.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
